- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02940353
The TREFOIL Concept 5 Year Clinical Investigation
The TREFOIL Concept: A Clinical Investigation in the Mandible on 3 Implants With a Fixed Prefabricated Framework
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Western Australia
-
Perth, Western Australia, Australia, 6005
- Branemark Centre
-
-
-
-
Santiago De Chile
-
Santiago, Santiago De Chile, Chile, 10373
- Clinica Rosenberg
-
-
-
-
-
Verona, Italy, 37131
- University of Verona
-
-
-
-
-
Alicante, Spain, 03016
- Instituto Davó, Hospital Medimar Internacional
-
-
-
-
Washington
-
Spokane, Washington, United States, 99216-1077
- Dr. Higuchi &Skinner
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Obtained informed consent from the subject.
- The subject is at least 18 years of age (passed cessation of growth) and not older than 80 years.
- The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems.
- The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based) or soft tissue born denture.
- The subject is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures).
- The subject is compliant with good oral hygiene.
- The subject has an edentulous mandible or failing mandibular dentition providing sufficient bone in the interforaminal where a fixed restoration on three (3) implants is regarded as an appropriate treatment solution.
- The subject has an osseous architecture enough to receive three implants with a length of at least 11.5 mm and a diameter of 5 mm in the interforaminal (e.g. jaw volume B, C or D; inter foramina distance at least 20 mm; buccal/lingual width at least 6-7 mm, vertical height after leveling bone sufficient to receive an implant of at least 11.5 mm length).
- The subject has a jaw curvature that fits to the prefabricated framework design.
- Implants will be placed in healed or extraction sites (clinical stability has to be ensured).
- The implant sites are free from infection and extraction remnants.
- The subjects as well as the implant sites fulfill the criteria for early loading.
Smokers that have reduced their consumption may be included after a certain test phase (e.g. test phase for reduction from 2 to 1 packages of cigarettes should be at least 6 months).
Class II inter-jaw relation patients are not an exclusion criteria per se. Based on the individual judgment of the clinician those patients may be treated.
Subject inclusion criteria at time of surgery
- After bone leveling sufficient mandible bone volume in the interforaminal present for three (3) implants with a length of at least 11.5 mm and a diameter of 5 mm.
- After bone leveling the jaw curvature does fit to the prefabricated framework.
- The implant sites are free from infection and extraction remnants.
- The subject as well as the implant sites fulfill the criteria for early loading.
Exclusion Criteria:
- The subject is not able to give her/his informed consent of participating.
- Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure.
- Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or history.
- Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation.
- Alcohol or drug abuse as noted in subject records or in subject history.
- Smoking of more than 1 package of cigarettes per day (> 20 cigarettes or equivalent).
- Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake or A1c level above 8%.
- Bisphosphonate therapy - based on individual judgment of the clinician (if intravenously administered or too high oral doses recently before surgery and during follow-up period).
- Pathologic occlusion, e.g. severe bruxism or other destructive habits.
- Lack of opposing dentition or unstable occlusion.
- Ongoing infections, endodontic or periodontal problems in opposing teeth or implants.
- Subject shows an unacceptable oral hygiene.
- Subject has allergic or adverse reactions to the restorative material.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Treatment with Trefoil concept
Treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cumulative survival rates for the implants
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- T-188
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edentulous or Failing Dentition Mandible
-
McGuire InstituteDentsply Sirona ImplantsRecruitingPartially Edentulous Maxilla or MandibleUnited States
-
University of Roma La SapienzaCompletedPartially Edentulous Maxilla, MandibleItaly
-
University of Roma La SapienzaCompletedPartially Edentulous Maxilla, Partially Edentulous MandibleItaly
-
Dhaka Dental College and HospitalBangladesh University of Engineering and TechnologyRecruitingDental Implantation | Partially Edentulous MandibleBangladesh
-
Cairo UniversityCompleted
-
Concordia Dent SrlCarol Davila University of Medicine and Pharmacy; MINECCompletedPartially Edentulous Maxilla | Partially Edentulous MandibleRomania
-
Biotech DentalCompletedTooth Loss | Partially Edentulous Maxilla | Partially Edentulous MandibleFrance
-
Medtronic Spinal and BiologicsAverion International Corporation; Baim Institute for Clinical ResearchWithdrawnAlveolar Bone Loss in Mandible | Edentulous Alveolar Ridge In Mandible
-
Concordia Dent SrlITI International Team for Implantology, SwitzerlandCompletedMANDIBLE | ATROPHYC EDENTULOUS JAWRomania
-
Cairo UniversityUnknownBilateral Edentulous Mandible (Kennedy Class I)Egypt
Clinical Trials on TREFOIL concept
-
University of ThessalyCompleted
-
University of IdahoNational Institutes of Health (NIH)Completed
-
Nutricia ResearchRecruitingGlycemic ResponseCanada
-
University Hospital, GhentRecruiting
-
University of JenaCompletedReduction of Cardiovascular Risk FactorsGermany
-
Nutricia ResearchRecruitingGlycemic ResponseCanada
-
University of ThessalyEnrolling by invitationPremature Birth | Parenting | Neonatal DiseaseGreece
-
University Hospital, Clermont-FerrandAustralian Catholic University; WittyFitUnknown
-
Nobel BiocareCompletedImplantBelgium, Italy, Lithuania, Netherlands